Influence of probenecid on the delivery of morphine-6-glucuronide to the brain

European Journal of Pharmaceutical Sciences

Volumn 24, Issue 1, 2005, Pages 49-57

  Tunblad, Karin ^a   Hammarlund Udenaes, Margareta ^a   Jonsson, E Niclas ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Blood brain barrier; Microdialysis; Modelling; Morphine 6 glucuronide; NONMEM and probenecid sensitive transport.

Indexed keywords

MORPHINE 6 GLUCURONIDE; PROBENECID;

ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CALIBRATION; CORPUS STRIATUM; DIALYSATE; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG TRANSPORT; JUGULAR VEIN; MALE; MICRODIALYSIS; MOLECULAR PROBE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; DRUG DELIVERY SYSTEMS; MALE; MORPHINE DERIVATIVES; PROBENECID; RATS; RATS, SPRAGUE-DAWLEY;

EID: 11144222951     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2004.09.009     Document Type: Article

References (33)

1. F.V. Abbott, and R.M. Palmour Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats Life Sci. 43 1988 1685 1695
2. S.L. Beal, and L.S. Sheiner NONMEM user's guide, NONMEM Project Group 1994 University of California at San Fransisco San Fransisco
3. U. Bickel, O.P. Schumacher, Y.S. Kang, and K. Voigt Poor permeability of morphine 3-glucuronide and morphine 6-glucuronide through the blood-brain barrier in the rat J. Pharmacol. Exp. Ther. 278 1996 107 113
4. F. Bourasset, S. Cisternino, J. Temsamani, and J.M. Scherrmann Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier J. Neurochem. 86 2003 1564 1567
5. M.R. Bouw, M. Gårdmark, and M. Hammarlund-Udenaes Pharmacokinetic-pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats - a microdialysis study Pharm. Res. 17 2000 1220 1227
6. M.R. Bouw, and M. Hammarlund-Udenaes Methodological aspects of the use of a calibrator in in vivo microdialysis - further development of the retrodialysis method Pharm. Res. 15 1998 1673 1679
7. M.R. Bouw, R. Xie, K. Tunblad, and M. Hammarlund-Udenaes Blood-brain barrier transport and brain distribution of morphine-6-glucuronide in relation to the antinociceptive effect in rats - pharmacokinetic/pharmacodynamic modelling Br. J. Pharmacol. 134 2001 1796 1804
8. P.M. Bungay, P.F. Morrison, and R.L. Dedrick Steady-state theory for quantitative microdialysis of solutes and water in vivo and in vitro Life Sci. 46 1990 105 119
9. M. Cvetkovic, B. Leake, M.F. Fromm, G.R. Wilkinson, and R.B. Kim OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine Drug Metab. Dispos. 27 1999 866 871
10. E.C. de Lange, G. de Bock, A.H. Schinkel, A.G. de Boer, and D.D. Breimer BBB transport and P-glycoprotein functionality using MDR1A (-/-) and wild-type mice Total brain versus microdialysis concentration profiles of rhodamine-123 Pharm. Res. 15 1998 1657 1665
11. S. Desrayaud, P. Guntz, J.M. Scherrmann, and M. Lemaire Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine Life Sci. 61 1997 153 163
12. B. Frances, R. Gout, B. Monsarrat, J. Cros, and J.M. Zajac Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine J. Pharmacol. Exp. Ther. 262 1992 25 31
13. M. Gårdmark, and M. Hammarlund-Udenaes Delayed antinociceptive effect following morphine-6-glucuronide administration in the rat - pharmacokinetic/pharmacodynamic modelling Pain 74 1998 287 296
14. M. Hammarlund-Udenaes, L.K. Paalzow, and E.C. de Lange Drug equilibration across the blood-brain barrier - pharmacokinetic considerations based on the microdialysis method Pharm. Res. 14 1997 128 134
15. J. Huwyler, J. Drewe, C. Klusemann, and G. Fricker Evidence for P-glycoprotein-modulated penetration of morphine-6-glucuronide into brain capillary endothelium Br. J. Pharmacol. 118 1996 1879 1885
16. S.P. Joel, R.J. Osborne, and M.L. Slevin An improved method for the simultaneous determination of morphine and its principal glucuronide metabolites J. Chromatogr. 430 1988 394 399
17. E.N. Jonsson, and M.O. Karlsson Xpose - an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM Comput. Methods Progr. Biomed. 58 1999 51 64
18. C. Julien-Dolbec, I. Tropres, O. Montigon, H. Reutenauer, A. Ziegler, M. Decorps, and J.F. Payen Regional response of cerebral blood volume to graded hypoxic hypoxia in rat brain Br. J. Anaesth. 89 2002 287 293
19. S.P. Letrent, G.M. Pollack, K.R. Brouwer, and K.L. Brouwer Effects of a potent and specific P-glycoprotein inhibitor on the blood-brain barrier distribution and antinociceptive effect of morphine in the rat Drug Metab. Dispos. 27 1999 827 834
20. J. Lötsch, R. Schmidt, G. Vetter, H. Schmidt, E. Niederberger, G. Geisslinger, and I. Tegeder Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein J. Neurochem. 83 2002 241 248
21. J. Lötsch, R. Schmidt, G. Vetter, H. Schmidt, C. Skarke, E. Niederberger, G. Geisslinger, and I. Tegeder The influence of inhibition of probenecid sensitive transporters on the central nervous system (CNS) uptake and the antinociceptive activity of morphine-6-glucuronide in rats Neurosci. Lett. 329 2002 145 148
22. I. Megard, A. Garrigues, S. Orlowski, S. Jorajuria, P. Clayette, E. Ezan, and A. Mabondzo A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation. Brain Res. 15 2002 153 167
23. D. Paul, K.M. Standifer, C.E. Inturrisi, and G.W. Pasternak Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite J. Pharmacol. Exp. Ther. 251 1989 477 483
24. H. Potschka, and W. Loscher In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats Epilepsia 42 2001 1231 1240
25. G.A. Rosenberg, W.T. Kyner, and E. Estrada Bulk flow of brain interstitial fluid under normal and hyperosmolar conditions Am. J. Physiol. 238 1980 42 49
26. A.H. Schinkel, J.J. Smit, O. van Tellingen, J.H. Beijnen, E. Wagenaar, L. van Deemter, and C.A. Mol Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs Cell 77 1994 491 502
27. S.L. Shafer, L.C. Siegel, J.E. Cooke, and J.C. Scott Testing computer-controlled infusion pumps by simulation Anesthesiology 68 1988 261 266
28. G. Skopp, L. Potsch, B. Ganssmann, R. Aderjan, and R. Mattern A preliminary study on the distribution of morphine and its glucuronides in the subcompartments of blood J. Anal. Toxicol. 22 1998 261 264
29. D. Sugiyama, H. Kusuhara, Y. Shitara, T. Abe, P.J. Meier, T. Sekine, H. Endou, H. Suzuki, and Y. Sugiyama Characterization of the efflux transport of 17beta-estradiol-d-17beta-glucuronide from the brain across the blood-brain barrier J. Pharmacol. Exp. Ther. 298 2001 316 322
30. I. Szentistvanyi, C.S. Patlak, R.A. Ellis, and H.F. Cserr Drainage of interstitial fluid from different regions of rat brain Am. J. Physiol. 246 1984 F835 F844
31. K. Tunblad, E.N. Jonsson, and M. Hammarlund-Udenaes Morphine blood-brain barrier transport is influenced by probenecid co-administration Pharm. Res. 20 2003 618 623
32. K. Tunblad, M. Hammarlund-Udenaes, and E.N. Jonsson An integrated model for the analysis of pharmacokinetic data from microdialysis experiments Pharm. Res. 21 2004 1698 1707
33. S.L. Wong, K. van Belle, and R.J. Sawchuk Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis J. Pharmacol. Exp. Ther. 264 1993 899 909